Salbutamol 4mg tablet (DrugBank: Salbutamol)
14 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
3 | 脊髄性筋萎縮症 | 0 |
11 | 重症筋無力症 | 1 |
12 | 先天性筋無力症候群 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
49 | 全身性エリテマトーデス | 0 |
85 | 特発性間質性肺炎 | 0 |
86 | 肺動脈性肺高血圧症 | 0 |
89 | リンパ脈管筋腫症 | 0 |
111 | 先天性ミオパチー | 0 |
113 | 筋ジストロフィー | 0 |
228 | 閉塞性細気管支炎 | 0 |
231 | α1-アンチトリプシン欠乏症 | 0 |
256 | 筋型糖原病 | 0 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03914638 (ClinicalTrials.gov) | April 1, 2019 | 11/4/2019 | Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis | Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis | Myasthenia Gravis | Drug: Salbutamol 4Mg Tablet;Drug: Placebo oral capsule | University of Aarhus | NULL | Recruiting | 18 Years | N/A | All | 30 | Phase 2;Phase 3 | Denmark |